Dipeptidyl peptidase-4 inhibitors

DRUG2 trials

Sponsors

Novo Nordisk A/S, Ain Shams University

Conditions

Diabetes Mellitus, Type 2Time in Range

Phase 2

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

CompletedNCT03751657

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2018-11-29End: 2020-01-17Updated: 2021-04-02

Phase 3

Feasibility of DPP-4 Inhibitor Therapy on Advanced Hybrid Closed Loop System

CompletedNCT06021119

Ain Shams UniversityTime in Range

Start: 2023-03-23End: 2023-04-21Updated: 2023-09-01

Related Papers

Mitigating iftar-related glycemic excursions in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed loop system: a randomized clinical trial for adjunctive oral vildagliptin therapy during Ramadan fasting.

2023-12-076 citations

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment

New England Journal of Medicine2020-09-22201 citations